High mobility group protein B1 controls liver cancer initiation through yes‐associated protein ‐dependent aerobic glycolysis
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Emerging studies have suggested that the Hippo pathway is involved in the tumorigenesis of hepatocellular carcinoma (HCC). However, the key regulator of the Hippo pathway in liver tumor metabolic reprogramming remains elusive. Here, we provide evidence that high mobility group box 1 (HMGB1), a chromosomal protein, plays a role in the regulation of the Hippo pathway during liver tumorigenesis. Cre/loxP recombination‐mediated HMGB1 depletion in hepatocytes blocks diethylnitrosamine‐induced liver cancer initiation in mice, whereas short hairpin RNA‐mediated gene silencing of HMGB1 inhibits HCC cell proliferation. Mechanistically, the binding of HMGB1 to GA‐binding protein alpha promotes the expression of yes‐associated protein (YAP), a major downstream effector of the Hippo pathway that contributes to liver tumorigenesis by inducing hypoxia‐inducible factor 1α (HIF1α)‐dependent aerobic glycolysis. Like wild‐type YAP‐complementary DNA, YAP‐5SA‐S94A can restore HIF1α DNA binding activity, glycolysis‐associated gene expression, and HIF1α–YAP complex formation in YAP‐knockdown HCC cell lines. In contrast, verteporfin, a reagent targeting the interface between YAP and TEA domain transcription factor, has the ability to block YAP–HIF1α complex formation. Notably, genetic or pharmacologic inhibition of the HMGB1–YAP–HIF1α pathway confers protection against excessive glycolysis and tumor growth in mice. Conclusion: These findings demonstrate that HMGB1 plays a novel role in modulating the YAP‐dependent HIF1α pathway and shed light on the development of metabolism‐targeting therapeutics for HCC chemoprevention. (H epatology 2018;67:1823‐1841)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
YAP/TAZ at the Roots of Cancer
Zanconato, F., Cordenonsi, M., & Piccolo, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.005 · Cited by 1,970 · cited 2×
“Similarly, dysregulation of the Hippo pathway can also trigger tumorigenesis in Drosophila and mice through multiple mechanisms.((1-3)) The core components of the Hippo pathway are composed of a regulatory serine–threonine kinase module (e.”
BackgroundMethodLiu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452
Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956 · cited 1×
“Abnormal expression and release of HMGB1 are implicated in multiple human diseases.((9)) HMGB1 has been reported to play dual roles in tumorigenesis depending on tumor type and its subcellular distribution.”
BackgroundSelf-citationEndogenous HMGB1 regulates autophagy
Tang, D., Kang, R., Livesey, K. M., Cheh, C.-W., Farkas, A., Loughran, P., Hoppe, G., Bianchi, M. E., Tracey, K. J., Zeh, H. J., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200911078 · Cited by 951 · cited 2×
“While most studies investigating the action of HMGB1 in tumorigenesis have focused on its DNA repair and proinflammatory activity capabilities,((26)) HMGB1 also plays metabolic roles involved in the regulation of autophagy that may contribute to drug resistance.((15)) Macrophages can release HMGB1 to trigger an inflam…”
BackgroundMethodSelf-citationUltraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
Bald, T., Quast, T., Landsberg, J., Rogava, M., Glodde, N., Lopez-Ramos, D., Kohlmeyer, J., Riesenberg, S., van den Boorn-Konijnenberg, D., Hömig-Hölzel, C., et al. (2014) · Nature · doi:10.1038/nature13111 · Cited by 623 · cited 1×
“While most studies investigating the action of HMGB1 in tumorigenesis have focused on its DNA repair and proinflammatory activity capabilities,((26)) HMGB1 also plays metabolic roles involved in the regulation of autophagy that may contribute to drug resistance.”
BackgroundNguyen, H. B., Babcock, J. T., Wells, C. D., & Quilliam, L. A. (2013) · Oncogene · doi:10.1038/onc.2012.431 · Cited by 84 · cited 1×
“Additionally, genetic knockdown of YAP reduces subcutaneous tumor growth of HCC lines.((7)) The widespread expression and activation of YAP in human liver cancer further implicates YAP as an important HCC therapeutic target.”
Background
Cited by
Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
Yang, Y., Kim, S., & Seki, E. (2019) · Seminars in Liver Disease · doi:10.1055/s-0038-1676806 · Cited by 449
The multifunctional protein HMGB1: 50 years of discovery
Tang, D., Kang, R., Zeh, H. J., & Lotze, M. T. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00894-6 · Cited by 371
Self-citationDanger signals in liver injury and restoration of homeostasis
Han, H., Desert, R., Das, S., Song, Z., Athavale, D., Ge, X., & Nieto, N. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.033 · Cited by 127
HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis
Hernandez, C., Huebener, P., Pradere, J.-P., Antoine, D. J., Friedman, R. A., & Schwabe, R. F. (2018) · Journal of Clinical Investigation · doi:10.1172/jci91786 · Cited by 110
Boicean, A., Birsan, S., Ichim, C., Boeras, I., Roman-Filip, I., Blanca, G., Bacila, C., Fleaca, R. S., Dura, H., & Roman-Filip, C. (2023) · Biomedicines · doi:10.3390/biomedicines11072058 · Cited by 23
Metadata
- Authors
- Chen, R., Zhu, S., Fan, X., Wang, H., Lotze, M. T., Zeh, H. J., Billiar, T. R., Kang, R., & Tang, D.
- Venue
- Hepatology
- Published
- 2018-04-01
- Volume
- 67
- Issue
- 5
- Pages
- 1823-1841
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2770278590
- Cited by
- 142
- References
- 8
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High mobility group protein B1 controls liver cancer initiation through yes‐associated protein ‐dependent aerobic glycolysis. https://app.cochat.ai/papers/10.1002/hep.29663
- The paper
- Chen, R., Zhu, S., Fan, X., Wang, H., Lotze, M. T., Zeh, H. J., Billiar, T. R., Kang, R., & Tang, D. (2018). High mobility group protein B1 controls liver cancer initiation through yes‐associated protein ‐dependent aerobic glycolysis. Hepatology. https://doi.org/10.1002/hep.29663
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.